Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Continucare Corporation Reports 81% Increase in Revenues and 185% Increase in Operating Profit for Fourth Quarter of Fiscal 2007

Posted on: Wednesday, 12 September 2007, 09:02 CDT

Continucare Corporation (AMEX:CNU) today reported financial results for its fourth quarter of fiscal 2007 and the fiscal year ended June 30, 2007. Financial highlights for the quarter include:

-- Total revenue of $65.4 million, an 81% increase compared to $36.2 million in the fourth quarter of fiscal 2006;

-- Income from operations of $3.7 million, a 185% increase compared to $1.3 million for the same period last year; and

-- Net income of $2.4 million, or $0.03 per diluted share, as compared to $1.1 million, or $0.02 per diluted share, for the same period a year ago.

Full Year Results

For the fiscal year ended June 30, 2007, total revenue increased 63% to $217.1 million compared to $133.0 million in the prior fiscal year. Income from operations during fiscal 2007 increased 24% to $9.9 million compared to $7.9 million for fiscal 2006. Net income for fiscal 2007 was $6.3 million, or $0.10 per diluted share, compared to $5.3 million, or $0.10 per diluted share, for fiscal 2006.

Balance Sheet

Continucare's cash and cash equivalents were $7.3 million at June 30, 2007 compared to $10.7 million at June 30, 2006, while working capital was $16.6 million at June 30, 2007 compared to $15.6 million at June 30, 2006. Total liabilities were $12.9 million at June 30, 2007 as compared to $5.0 million at June 30, 2006. Shareholders' equity increased to $104.1 million at June 30, 2007 from $37.0 million at June 30, 2006.

"We are very pleased with the financial results for both our fourth fiscal quarter and our full fiscal year," said Richard C. Pfenniger, Jr., Continucare's Chairman and Chief Executive Officer. "Our revenues, profits and cash flow from operations increased significantly, and at fiscal year-end our balance sheet remained virtually free of long-term indebtedness. We are also pleased that while achieving these results we took actions to support future growth. These actions include the acquisition of the Miami Dade Health Centers, which significantly expanded the breadth and scope of our operations. In addition, during fiscal 2007 we conceived of and began the effort to launch Continucare ValuClinic™, a new line of retail-based convenient care clinics. We currently expect to open our first ValuClinic locations this Fall. Overall, this is a very exciting period for Continucare and we are optimistic about our prospects."

Stock Repurchase Program

Under our previously announced stock repurchase program, our Board authorized the buy back of up to 2.5 million shares of our common stock. Approximately 1.34 million shares remain available for repurchase under this program and management intends to repurchase shares under the program based on its assessment of market conditions from time to time. Purchases will be reported on a quarterly basis in Continucare's periodic reports filed with the SEC.

About Continucare ValuClinic™

Continucare ValuClinic™ is a new line of consumer-oriented, retail-based health centers which will offer treatment for common illnesses such as the flu, bronchitis, strep throat, pink eye, skin infections and seasonal allergies, in a quick, convenient, and patient-friendly health care setting. Continucare ValuClinic™ will also offer other high demand health care services such as common vaccinations, physical examinations and diagnostic screenings. The clinics will be staffed primarily by certified nurse practitioners and physician assistants and will be open seven days a week with extended hours on weekdays. No appointment will be necessary and fees for services will represent a meaningful discount to care provided in more traditional health care settings. For more information please visit www.valuclinic.net.

About Continucare Corporation

Continucare provides primary care physician services on an outpatient basis through a network of medical facilities and independent physician affiliates (IPAs) in the State of Florida. Continucare has 18 medical offices equipped with state-of-the-practice technology and staffed with experienced physicians and a comprehensive support staff. In addition, Continucare provides health practice management services to IPAs who practice primary care medicine in South Florida. Continucare assists these physicians with medical utilization and pharmacy management and specialist network development, freeing them to devote more time to patient care. Currently, through its network of medical facilities and IPAs, Continucare provides health care services for approximately 40,000 patients. For more information please visit www.continucare.com.

Except for historical matters contained herein, statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors and others are cautioned that forward-looking statements are subject to risks and uncertainties that may affect our business and prospects and cause our actual results to differ materially from those set forth in the forward-looking statements. These factors include, without limitation, the risk that the current trend in revenue or income growth may not continue or may be less than anticipated, risks and uncertainties relating to our ability to implement our growth strategy and to manage future growth, including our ability to achieve expected levels of patient volumes and control the costs of providing services, risks and uncertainties relating to our acquisition of Miami Dade Health Centers, Inc. and its affiliated companies, including the risk that we may not realize the expected benefits of the acquisition and that the acquisition may not ultimately be accretive to earnings, the risk that we may be unable to successfully complete the integration of the Miami Dade Health Centers companies into our business and achieve expected synergies, and the risk that further restructuring or other acquisition-related charges may be required in future periods, risks relating to the timely opening of Continucare ValuClinic health centers as currently scheduled, risks relating to pricing and other pressures exerted on us by managed care organizations, the risk that the impact of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 and the Medicare Risk Adjustment on payments we receive for our managed care operations may not continue to be positive for us and that risk corridor adjustment charges in future periods may be greater than in the past, the risk that future legislation, changes in governmental regulations, including possible changes in Medicare programs, could adversely impact our operations or reduce reimbursements to health care providers and insurers, risks and uncertainties relating to our current dependence on three HMOs for substantially all of our revenues, including the loss of our managed care agreements with any of these HMOs and our ability to work together effectively with our HMO affiliates, uncertainties relating to technological and pharmaceutical improvements that increase the cost of providing, or reduce the demand for, health care, and general economic conditions and uncertainties generally associated with the health care business. These and other applicable risks, cautionary statements and factors that could cause actual results to differ from our forward-looking statements are included in our annual report on Form 10-K for the fiscal year ended June 30, 2006 and other filings with the SEC. We undertake no obligation to update or revise these forward-looking statements to reflect events or circumstances after the date hereof except as required by law.

CONTINUCARE CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

June 30,

ASSETS

 

2007

 

 

 

2006

 

Current assets:

Cash and cash equivalents

$

7,262,247

$

10,681,685

Other receivables, net

308,111

231,832

Due from HMOs, net of a liability for incurred but not reported medical claims expense of approximately $23,618,000 and $14,207,000 at June 30, 2007 and 2006, respectively

13,525,092

6,339,526

Prepaid expenses and other current assets

1,273,593

689,096

Deferred tax assets

 

740,264

 

 

658,768

 

Total current assets

23,109,307

18,600,907

Certificates of deposit, restricted

1,176,635

1,126,987

Property and equipment, net

8,509,454

824,220

Goodwill, net of accumulated amortization of approximately $7,610,000

73,670,225

14,342,510

Intangible assets, net of accumulated amortization of $929,000

7,731,000

-

Managed care contracts, net of accumulated amortization of approximately $3,126,000 and $2,773,000 at June 30, 2007 and 2006, respectively

384,422

737,234

Deferred tax assets

2,289,811

5,810,562

Other assets, net

 

66,694

 

 

551,927

 

Total assets

$

116,937,548

 

$

41,994,347

 

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

1,007,869

$

575,925

Accrued expenses and other current liabilities

4,542,097

2,377,505

Income taxes payable

 

910,739

 

 

24,428

 

Total current liabilities

6,460,705

2,977,858

Capital lease obligations, less current portion

165,191

112,068

Deferred tax liabilities

6,215,483

1,929,501

Other liability

 

37,784

 

 

-

 

Total liabilities

12,879,163

5,019,427

Commitments and contingencies

Shareholders' equity:

Common stock, $0.0001 par value: 100,000,000 shares authorized; 70,043,086 shares issued and outstanding at June 30, 2007 and 50,242,478 shares issued and outstanding at June 30, 2006

7,004

5,024

Additional paid-in capital

124,616,091

63,838,051

Accumulated deficit

 

(20,564,710

)

 

(26,868,155

)

Total shareholders' equity

 

104,058,385

 

 

36,974,920

 

Total liabilities and shareholders' equity

$

116,937,548

 

$

41,994,347

 

CONTINUCARE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

 

(Unaudited)

Three-Months Ended

 

Year Ended

 

6/30/07

 

 

6/30/06

 

 

6/30/07

 

 

6/30/06

 

Revenue:

Medical services revenue

$

65,374,523

$

36,192,717

$

216,878,488

$

132,629,665

Management fee revenue and other income

 

67,403

 

 

19,535

 

 

267,799

 

 

361,247

 

Total revenue

65,441,926

36,212,252

217,146,287

132,990,912

 

Operating expenses:

Medical services:

Medical claims

48,682,355

28,141,372

161,153,828

97,781,447

Other direct costs

 

6,439,063

 

 

3,373,086

 

 

22,919,746

 

 

13,137,396

 

Total medical services

55,121,418

31,514,458

184,073,574

110,918,843

Administrative payroll and employee benefits

2,288,807

1,544,635

9,192,670

6,538,295

General and administrative

 

4,285,951

 

 

1,837,454

 

 

13,990,439

 

 

7,584,205

 

Total operating expenses

 

61,696,176

 

 

34,896,547

 

 

207,256,683

 

 

125,041,343

 

 

Income from operations

3,745,750

1,315,705

9,889,604

7,949,569

 

Other income (expense):

Interest income

87,027

121,778

356,192

331,001

Interest expense

 

(4,808

)

 

(2,291

)

 

(49,746

)

 

(12,870

)

Income before income tax provision

3,827,969

1,435,192

10,196,050

8,267,700

Income tax provision

 

1,450,757

 

 

327,020

 

 

3,892,605

 

 

2,930,161

 

Net income

$

2,377,212

 

$

1,108,172

 

$

6,303,445

 

$

5,337,539

 

 

Net income per common share:

Basic

$

.03

 

$

.02

 

$

.10

 

$

.11

 

Diluted

$

.03

 

$

.02

 

$

.10

 

$

.10

 

 

Weighted average common shares outstanding:

Basic

 

70,043,171

 

 

50,197,034

 

 

65,044,319

 

 

49,907,898

 

Diluted

 

71,434,846

 

 

51,516,141

 

 

66,324,613

 

 

51,230,435

 

CONTINUCARE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Year Ended June 30,

 

2007

 

 

 

2006

 

CASH FLOWS FROM OPERATING ACTIVITIES

Net income

$

6,303,445

$

5,337,539

Adjustments to reconcile net income to net cash provided by operating activities:

 

Depreciation and amortization

2,013,486

695,095

Loss on disposal of fixed assets

35,924

--

Provision for bad debts

165,181

163,105

Compensation expense related to issuance of stock options

1,692,190

1,292,234

Excess tax benefits related to exercise of stock options

(523,964

)

--

Deferred tax expense

2,172,618

2,767,095

Changes in operating assets and liabilities, excluding the effect of disposals:

Other receivables

(241,460

)

(249,964

)

Due from HMOs, net

(1,803,016

)

(2,853,996

)

Prepaid expenses and other current assets

(629,497

)

30,481

Other assets

151,360

(125,964

)

Accounts payable

369,688

(84,214

)

Accrued expenses and other current liabilities

(275,196

)

8,354

Income taxes payable

 

1,419,894

 

 

(106,934

)

Net cash provided by continuing operations

10,850,653

6,872,831

Net cash used in discontinued operations

 

--

 

 

(32,512

)

Net cash provided by operating activities

10,850,653

6,840,319

 

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of certificate of deposit

(49,648

)

(596,637

)

Proceeds from sales of fixed assets

70,000

-

Acquisition of MDHC Companies, net of cash acquired

(6,109,980

)

-

Purchase of property and equipment

(894,325

)

(280,675

)

Other assets

 

--

 

 

(359,147

)

Net cash used in investing activities

(6,983,953

)

(1,236,459

)

 

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from note payable

1,813,317

-

Repayments on note payable

(1,813,317

)

(520,000

)

Proceeds from long-term debt

6,917,808

-

Repayment on long-term debt

(14,690,960

)

-

Principal repayments under capital lease obligations

(96,248

)

(127,053

)

Proceeds from exercise of stock options

103,700

640,468

Excess tax benefits related to exercise of stock options

523,964

-

Payment of fees related to issuance of stock

(44,402

)

-

Repurchase and retirement of common stock

 

--

 

 

(696,134

)

Net cash used in financing activities

 

(7,286,138

)

 

(702,719

)

 

Net (decrease) increase in cash and cash equivalents

(3,419,438

)

4,901,141

Cash and cash equivalents at beginning of fiscal year

 

10,681,685

 

 

5,780,544

 

Cash and cash equivalents at end of fiscal year

$

7,262,247

 

$

10,681,685

 

 

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING TRANSACTIONS:

Purchase of equipment, furniture and fixtures with proceeds of capital lease obligations

$

171,135

 

 

$

215,162

 

Retirement of treasury stock

$

--

 

$

5,424,701

 

Stock issued upon conversion of related party notes payable

$

--

 

$

102,180

 

CONTINUCARE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

 

Year Ended June 30,

 

2007

 

 

 

2006

Information with respect to MDHC acquisition accounted for under the purchase method of accounting is summarized as follows:

 

Fair value of assets acquired

$

22,244,088

$

--

Liabilities assumed

 

(15,375,217

)

 

--

Net assets acquired

 

6,868,871

 

 

--

Purchase price:

Cash paid to principal owners of MDHC

5,709,937

--

Acquisition costs

982,081

--

Cash to be paid related to acquisition

1,000,000

--

Fair market value of stock issued

 

58,504,568

 

 

--

Total

 

66,196,586

 

 

 

--

Goodwill

$

59,327,715

 

$

--

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Cash paid for taxes

$

306,000

 

$

270,000

Cash paid for interest

$

49,746

 

$

12,870


Source: Business Wire

More News in this Category


Related Articles



Rating: 3.0 / 5 (6 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required